Cannabis Strategic Ventures (OTC: NUGS) this morning
announced a major common share restructuring. The company has cancelled a total
of 75.6 million shares, including 20 million from the company’s chief executive
officer Simon Yu. The move to cancel approximately 25% of the total shares is
intended to raise shareholder value and build long-term value for all. The
restructuring follows the company’s recently announced partnerships with
Fitamins and Asher House Pet CBD, both of which operate in the multi-million
dollar CBD products market. “The future of Cannabis Strategic Ventures is all
about acquiring and partnering with the best brands in the fast-growing
cannabis marketplace. The streamlined share structure will continue to make our
company an attractive partner as we work toward signing other similar brands
and distribution partnerships,” Cannabis Strategic Ventures CEO Simon Yu stated
in the news release.
To view the full press release, visit http://ibn.fm/wjMUk
About Cannabis Strategic Ventures, Inc.
Cannabis Strategic Ventures is based in Los Angeles and is
focused on supporting entrepreneurial growth within the fast-growing legal
cannabis sector. The Company recently completed a name and symbol change from
Cascade Energy, Inc. Cannabis Strategic Ventures offers outsourced personnel
solutions that are tailor made to match the growth dynamics of cannabis
cultivators, manufacturers, dispensaries, and other cannabis marketplace
participants. Cannabis Strategic Ventures is publicly traded on the U.S. Over the
Counter Market with the stock symbol NUGS. For more information, visit the
company’s website at www.CannabisStrategic.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
